Physician Profile

Michael A. Azrin, M.D.

Professor of Medicine
Director, Cardiac Catheterization Laboratory
Director, Interventional Cardiology
Director, Interventional Cardiology Fellowship Program

Dr. Azrin is a fellow of the American College of Cardiology and the American Heart Association (AHA). He also serves on the AHA Arteriosclerosis, Thrombosis and Vascular Biology Council.

Office Locations:

Pat and Jim Calhoun Cardiology Center
UConn Health
263 Farmington Avenue
Farmington, CT 06030

Board Certifications:
  • Internal Medicine
  • Cardiovascular Disease
  • Interventional Cardiology
Education and Training:
Undergraduate SchoolBrandeis UniversityBiology
Medical SchoolWashington University School of MedicineMedicine
FellowshipYale UniversityClinical Cardiology
FellowshipHartford HospitalInterventional Cardiology
InternshipJewish Hospital of Washington UniversityInternal Medicine
ResidencyJewish Hospital of Washington UniversityInternal Medicine
Hospital Affiliation:
  • John Dempsey Hospital
Selected Publications:

Peer Reviewed Publications

Multi-vessel versus culprit-vessel and staged percutaneous coronary intervention in STEMI patients with multivessel disease: a meta-analysis of randomized controlled trials. Dahal, Khagendra; Rijal, Jharendra; Panta, Raju; Lee, Juyong; Azrin, Michael; Lootens, Robert. (2014). Cardiovascular revascularization medicine : including molecular interventions, 8, (15), 408-13.

Exercise during cardiac catheterization distinguishes between pulmonary and left ventricular causes of dyspnea in systemic sclerosis patients. Hager, W David; Collins, Irina; Tate, Janet P; Azrin, Michael; Foley, Raymond; Lakshminarayanan, Santha; Rothfield, Naomi F. (2013). The clinical respiratory journal, 3, (7), 227-36.

Survival of geriatric idiopathic pulmonary arterial hypertension patients. Foley, Raymond J; Wilcox, Diahann; Walsh, Stephen J; Azrin, Michael; Hager, W David. (2011). Connecticut medicine, 1, (75), 11-5.

Rheolytic thrombectomy with percutaneous coronary intervention for infarct size reduction in acute myocardial infarction: 30-day results from a multicenter randomized study. Ali, Arshad; Cox, David; Dib, Nabil; Brodie, Bruce; Berman, Daniel; Gupta, Navin; Browne, Kevin; Iwaoka, Robert; Azrin, Michael; Stapleton, Dwight; Setum, Cindy; Popma, Jeffrey. (2006). Journal of the American College of Cardiology, 2, (48), 244-52.

The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis. Henry, Timothy D; Annex, Brian H; McKendall, George R; Azrin, Michael A; Lopez, John J; Giordano, Frank J; Shah, P K; Willerson, James T; Benza, Raymond L; Berman, Daniel S; Gibson, C Michael; Bajamonde, Alex; Rundle, Amy Chen; Fine, Jennifer; McCluskey, Edward R. (2003). Circulation, 10, (107), 1359-65.